title: [Morphologic evaluation of systemic chemotherapy for gastric cancer--using new criteria of the Research Society for Gastric Cancer].
authors.forename: H
authors.initials: H
authors.lastname: Iwase
authors.forename: K
authors.initials: K
authors.lastname: Morise
authors.forename: S
authors.initials: S
authors.lastname: Suga
authors.forename: K
authors.initials: K
authors.lastname: Ina
authors.forename: N
authors.initials: N
authors.lastname: Takeda
authors.forename: T
authors.initials: T
authors.lastname: Matsuura
authors.forename: S
authors.initials: S
authors.lastname: Matsuoka
authors.forename: K
authors.initials: K
authors.lastname: Nomoto
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage; D011379:Prognosis; D013274:Stomach Neoplasms / Q000188:drug therapy*; D005641:Tegafur / Q000008:administration & dosage; D014498:Uracil / Q000008:administration & dosage
chemical_list: D008937:Mitomycins; D005641:Tegafur; D016685:Mitomycin; D014498:Uracil